GleamWall
中文EN

CNMD CONMED Corp

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 816956 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY-64.5%
TTM EPS YoY-64.5%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR—

Margins

Gross margin54.6%
Operating margin7.5%
Net margin3.4%
FCF margin11.0%
EBITDA margin8.7%

Returns

ROE4.7%
ROA2.0%
ROIC (approx.)3.7%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets55.6%
Debt / equity0.81x
Current ratio2.14x
Interest coverage3.30x

Cash quality & payout

Operating cash flow / net income3.63x
Accruals ratio-5.3%
Payout ratio52.6%
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.37B$1.31B
Cost of revenue$624.25M$573.98M
Gross profit$750.48M$733.03M
R&D expense$55.88M$54.43M
SG&A expense$591.97M$478.28M
Operating income$102.62M$200.33M
Interest expense$31.09M$37.30M
Pretax income$71.12M$163.03M
Income tax$24.06M$30.61M
Net income$47.05M$132.42M
EBITDA$119.77M$216.93M
EPS (basic)1.524.29
EPS (diluted)1.514.25
Dividends declared per share0.600.80
Weighted avg. shares (diluted)31.15M31.15M
Balance sheet
Cash & equivalents$40.82M$24.46M
Receivables$247.83M$237.73M
Inventory$355.54M$346.72M
Current assets$672.86M$640.01M
PP&E, net$113.33M$115.79M
Goodwill$807.01M$805.36M
Intangibles$582.05M$617.66M
Total assets$2.33B$2.31B
Current liabilities$315.04M$278.13M
Short-term debt$712,000$715,000
Long-term debt$834.23M$905.07M
Total debt$834.94M$905.78M
Total liabilities$1.29B$1.34B
Shareholders' equity$1.03B$962.68M
Net debt$794.12M$881.32M
Cash flow statement
Operating cash flow$170.69M$166.97M
Capital expenditure$19.81M$13.08M
Free cash flow$150.88M$153.88M
Investing cash flow-$20.96M-$13.08M
Financing cash flow-$135.82M-$151.00M
Depreciation & amortization$17.14M$16.61M
Stock-based compensation$28.32M$25.56M
Dividends paid$24.75M$24.65M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.